Federal records show nearly $800,000 in U.S. health funds flowed to a project tied to a Russian plague-linked institute while Robert F. Kennedy Jr. led the department overseeing those grants.
Story Snapshot
- Records cite $779,689 awarded to a University of Illinois project with a Russian state research partner.
- The partner has ties to Siberia’s anti-plague network amid reports of a fatal lab incident there.
- Media coverage ties the grants to the period Robert F. Kennedy Jr. served as Health and Human Services Secretary.
- The episode revives concerns about risky foreign lab ties and biosafety oversight.
What The Records Show About The Grant Money
Media reporting states that the National Institutes of Health awarded $779,689 to the University of Illinois Urbana-Champaign in 2025 and 2026 for a collaborative project with Russia’s state-run Institute of Cytology and Genetics. The reports describe two disbursements, about $389,943 in July 2025 and $389,746 in September 2026, during Robert F. Kennedy Jr.’s tenure leading the Department of Health and Human Services. The coverage frames the link as significant because of the Russian partner’s connection to a broader anti-plague research network.
The core fact is the federal award trail and the named partner institution. That is what anchors the claim and the public interest. The report does not allege that the U.S. project handled plague directly. It highlights that the collaboration involved a Russian state institute in a country where anti-plague labs operate. That detail matters because the same national network has drawn scrutiny after a reported fatal lab exposure in Siberia, which has raised fresh biosafety questions.
Why The Russian Connection Raises Red Flags Now
Recent reporting describes the death of a 28-year-old lab worker in Siberia tied to an anti-plague institute founded in the 1930s to fight plague and other dangerous diseases. That case has spurred international calls for transparency, as officials and experts seek clear data on the incident and risk. Against that backdrop, news that U.S. taxpayer money supported a university project with a Russian state research arm has renewed concern over cross-border research and safety oversight involving high-risk agents.
Legal, policy, and history debates often flare when American grants intersect with foreign high-containment work. Past programs have backed collaboration to reduce threats and improve security, but they also create oversight burdens and political risk if partners face safety lapses. Today’s concern centers on whether U.S. health agencies set and enforced strict guardrails for partners and projects, especially when relationships involve institutes linked to pathogen security missions within Russia’s public health system.
RFK Jr.’s Role And The Accountability Question
Media accounts tie the timeline of the grants to the period when Robert F. Kennedy Jr. served as Secretary of Health and Human Services, the department that houses the National Institutes of Health. Those reports assert he “oversaw” nearly $800,000 in funding to the University of Illinois project with the Russian state institute. That framing places accountability at the top of the agency, where leaders are expected to ensure spending aligns with U.S. security, science, and ethics standards.
🚨BREAKING: RFK is funding an NIH grant with a Siberian plague lab collaborator.
– A new White Coat Waste (WCW) investigation exposes $779,689 in new NIH funding under Secretary Robert F. Kennedy Jr. for an animal experimentation collaboration with a Russian lab that has…
— White Coat Waste (@WhiteCoatWaste) October 8, 2026
This moment calls for clear answers, not spin. Taxpayers deserve to know who reviewed the collaboration, what biosafety terms applied, and whether any continuing ties exist. Congress and the department can release grant files, risk assessments, and compliance reports. That transparency would show whether safeguards were tight, whether red flags were missed, and how the government now handles research that touches foreign labs with histories linked to dangerous pathogens.
What Comes Next For Oversight And Policy
Practical steps are available. The Department of Health and Human Services can pause similar collaborations pending review. The National Institutes of Health can update foreign-partner screening, bolster site audits, and require rapid disclosure of any lab incidents abroad tied to U.S.-funded work. Lawmakers can require public summaries for high-risk collaborations, detailing aims, biosafety levels, and data-sharing rules with U.S. authorities. These steps protect national security, public health, and the public purse.
Sources:
mediaite.com, apnews.com, presstv.ir
